Machine learning (ML) is viewed as the next generation solution for supporting decision-making and development by many industries, and the clinical research sector is no exception. But not all applications of this artificial intelligence technology are appropriate for clinical trials, say several researchers who have raised questions about its validity, reliability and scalability.